Search research articles
Contact Us
Filters
Showing results (151-160 of 210) with videos related to
Page
of 21
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 4, 2025
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC
Seshiru Nakazawa, Federica Pecci, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer
Biagio Ricciuti, Jieun Son, Jeffrey J Okoro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, et al.
Cancer Discovery
|
April 15, 2017
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer
Dennis O Adeegbe, Yan Liu, Patrick H Lizotte, et al.
JAMA Oncology
|
May 22, 2025
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer
Biagio Ricciuti, Francesca Fusco, Alissa Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung Cancer
Magda Bahcall, Mark M Awad, Lynette M Sholl, et al.
The New England Journal of Medicine
|
June 2, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
Patrick M Forde, Jonathan D Spicer, Mariano Provencio, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Science (New York, N.Y.)
|
November 15, 2014
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S Crystal, Alice T Shaw, Lecia V Sequist, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 210) with videos related to
Sort By:
Page
of 21
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 4, 2025
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC
Seshiru Nakazawa, Federica Pecci, Biagio Ricciuti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer
Biagio Ricciuti, Jieun Son, Jeffrey J Okoro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, et al.
Cancer Discovery
|
April 15, 2017
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer
Dennis O Adeegbe, Yan Liu, Patrick H Lizotte, et al.
JAMA Oncology
|
May 22, 2025
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer
Biagio Ricciuti, Francesca Fusco, Alissa Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung Cancer
Magda Bahcall, Mark M Awad, Lynette M Sholl, et al.
The New England Journal of Medicine
|
June 2, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
Patrick M Forde, Jonathan D Spicer, Mariano Provencio, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Science (New York, N.Y.)
|
November 15, 2014
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S Crystal, Alice T Shaw, Lecia V Sequist, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Page
of 21